Olanzapine dosing study for schizophrenia
Part of Mental health clinical trials.
This trial tests a slower, lower-dose schedule of the drug olanzapine for people with schizophrenia. It aims to see if a gentler start is safer and works as well, especially for those who may need less medication due to other health conditions.
Summary written for real people, not researchers, by Clin2.
Who can take part
- You have been diagnosed with schizophrenia for more than 1 year.
- Your doctor thinks a lower starting dose or slower increase of olanzapine would be better for you.
- You do not have other conditions like schizoaffective disorder, bipolar disorder, or major depression.
- You have not been hospitalized for worsening schizophrenia in the last 12 weeks.
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This study tests a new combination pill (olanzapine and samidorphan) for adults with schizophrenia. It aims to see if the combination helps control symptoms while potentially reducing weight gain, which is a common side effect of olanzapine.
This Phase 3 study tests a treatment aimed at reducing unhealthy weight gain in teens with schizophrenia or bipolar I disorder, using changes in BMI (a height-and-weight measure). It may help families who are concerned about weight changes that can happen with some psychiatric medicines.
This is an observational (non-intervention) study that follows adults with schizophrenia who are taking specific “atypical” antipsychotic medicines long-term. Researchers want to learn about patients’ experiences and outcomes while on these treatments.
This study looks at how well patients with bipolar disorder do while taking the medication olanzapine. You will continue your regular treatment, and answer questions about your experience.
This study compares whether slowly reducing antipsychotic medication is as effective as staying on the current dose for people with schizophrenia or related disorders. It uses a personalized approach to help you and your doctor decide which option may work best for you.
This trial looks at whether taking an antipsychotic every other day can keep symptoms controlled in adults with schizophrenia or another psychotic disorder. It may help some people avoid daily dosing, but it requires specific medication stability and screening checks.
Hear when a new Schizophrenia trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.